Articles
| Open Access |
https://doi.org/10.55640/
CUSHING SYNDROME: PATHOPHYSIOLOGY, DIAGNOSIS, AND CONTEMPORARY MANAGEMENT
Xasanova Nargis Qodirovna , Department of Fundamental Medical Sciences of the Asian International University, Bukhara, UzbekistanAbstract
Cushing syndrome is a rare but severe endocrine disorder characterized by chronic exposure to excess glucocorticoids, leading to significant morbidity and increased mortality. Despite advances in endocrinology, its heterogeneous etiology and overlapping clinical features continue to pose diagnostic and therapeutic challenges. Cushing syndrome is broadly classified into adrenocorticotropic hormone (ACTH)-dependent and ACTH-independent forms, each with distinct pathophysiological mechanisms. Advances in biochemical testing, imaging techniques, and invasive diagnostic procedures such as inferior petrosal sinus sampling have improved diagnostic accuracy. Surgical intervention remains the cornerstone of treatment, while medical therapies and radiotherapy serve as adjuncts or alternatives in selected cases. Persistent cardiovascular, metabolic, and neuropsychiatric complications may occur even after biochemical remission.
This review aims to provide a comprehensive overview of the current understanding of Cushing syndrome, focusing on its pathophysiology, etiological classification, diagnostic strategies, and contemporary management approaches based on recent literature.
Keywords
Cushing syndrome; hypercortisolism; ACTH-dependent; ACTH-independent; endocrine disorders; diagnostic approach; management
References
Nieman LK, Biller BMK, Findling JW, Murad MH, Newell-Price J, et al. Treatment of cushing’s syndrome: An endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. 2015;100(8):2807–2831. doi: 10.1210/jc.2015-1818.
Lindholm J, Juul S, Jørgensen JOL, Astrup J, Bjerre P, et al. Incidence and late prognosis of Cushing’s syndrome: A population-based study. Journal of Clinical Endocrinology and Metabolism. 2001;86(1):117–123. doi: 10.1210/jc.86.1.117.
Arnardóttir S, Sigurjonsdóttir HA. The incidence and prevalence of Cushing’s disease may be higher than previously thought: Results from a retrospective study in Iceland 1955 through 2009. Clinical Endocrinology. 2011;74(6):792–793. doi: 10.1111/j.1365-2265.2010.03961.x.
Bolland MJ, Holdaway IM, Berkeley JE, Lim S, Dransfield WJ, et al. Mortality and morbidity in Cushing’s syndrome in New Zealand. Clinical Endocrinology. 2011;75(4):436–442. doi: 10.1111/j.13652265.2011.04124.x.
Newell-Price J, Trainer P, Besser M, Grossman A. The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States. Endocrine Reviews. 1998;19(5):647–672. doi: 10.1210/edrv.19.5.0346.
Giraldi FP, Moro M, Cavagnini F. Gender-related differences in the presentation and course of Cushing’s disease. Journal of Clinical Endocrinology and Metabolism. 2003;88(4):1554–1558. doi: 10.1210/jc.2002-021518.
Lonser RR, Nieman L, Oldfield EH. Cushing’s disease: Pathobiology, diagnosis, and management. Journal of Neurosurgery. 2017;126(2):404–417. doi: 10.3171/2016.1.JNS152119.
Clayton RN, Raskauskiene D, Reulen RC, Jones PW. Mortality and morbidity in Cushing’s disease over 50 Years in Stoke-on-Trent, UK: Audit and meta-analysis of literature. Journal of Clinical Endocrinology and Metabolism. 2011;96(3):632–642. doi: 10.1210/jc.2010-1942.
Etxabe J, Vazquez JA. Morbidity and mortality in Cushing’s disease: An epidemiological approach. Clinical Endocrinology. 1994;40(4):479–484. doi: 10.1111/j.1365-2265.1994.tb02486.x.
Graversen D, Vestergaard P, Stochholm K, Gravholt CH, Jørgensen JOL. Mortality in Cushing’s syndrome: A systematic review and meta-analysis. European Journal of Internal Medicine. 2012;23(3):278–282. doi: 10.1016/j.ejim.2011.10.013.
Van Haalen FM, Broersen LHA, Jorgensen JO, Pereira AM, Dekkers OM. Management of endocrine disease: Mortality remains increased in Cushing’s disease despite biochemical remission: A systematic review and meta-analysis. European Journal of Endocrinology. 2015;172(4):R143–149. doi: 10.1530/EJE-14-0556.
Clayton RN, Jones PW, Reulen RC, Stewart PM, Hassan-Smith ZK, et al. Mortality in patients with Cushing’s disease more than 10 years after remission: A multicentre, multinational, retrospective cohort study. The Lancet Diabetes and Endocrinology. 2016;4(7):569–576. doi: 10.1016/S2213-8587(16)30005-5.
Article Statistics
Downloads
Copyright License

This work is licensed under a Creative Commons Attribution 4.0 International License.